Home » Topics » BioWorld Science

BioWorld Science
RSS

Close look illuminates ketamine's (relative) staying power

June 1, 2022

Cat model of Rdh5-associated retinopathy mimics the human phenotype

June 1, 2022

Anti-NOTCH3 treatment reverses experimental pulmonary arterial hypertension

June 1, 2022

Artemisinin derivatives as potential agents for the treatment of MS

June 1, 2022

Betta Pharmaceuticals describes histone acetyltransferase KAT3B inhibitors

June 1, 2022

Zydus Lifesciences patents bacterial dihydrofolate reductase inhibitors

June 1, 2022

New IL-17 modulators discovered at UCB

June 1, 2022

New tachykinin NK2 receptor agonists identified at Embark Biotech

June 1, 2022

Arvinas Operations describes PROTACs for androgen receptor degradation

June 1, 2022

NF1 mutation impacts neurons to modify tumor predisposition by increasing neuronal excitability

June 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...